跳至主要内容
临床试验/NCT07606794
NCT07606794招募中不适用

A Randomized Clinical Non-Inferiority Trial Comparing Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty

Tanta University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年5月23日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1

研究概览

简要总结

This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).

详细描述

Total hip arthroplasty (THA) is one of the most common elective orthopedic procedures, performed to restore mobility, alleviate pain and improve quality of life in patients with degenerative hip joint disease. Its rate is projected to further increase with aging of the population worldwide.

Pericapsular nerve group (PENG) block is a fascial block targets periarticular sensory branches derived from the femoral, obturator and accessory obturator nerves innervating the anterior hip capsule.

The ultrasound-guided quadratus lumborum block (QLB) is a regional anesthetic technique with many described approaches: the lateral QL (QL1) block, the posterior QL (QL2) block, and the anterior QL (transmuscular) block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 75 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) classification I-III.
  • Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.

排除标准

  • Known allergies to the drugs used.
  • Infection at the injection site.
  • Bleeding disorders.
  • Recognized neuromuscular disorders.
  • Opioid addiction or dependence.
  • Contraindications to regional anesthesia or peripheral nerve blockade.
  • Body mass index (BMI) > 40 kg/m².
  • Associated decompensated cardiac, hepatic, respiratory, or renal diseases.

研究组 & 干预措施

Group SA- QLB

Experimental

Patients will receive a supra-iliac anterior quadratus lumborum block (SA-QLB) using 20mL of bupivacaine 0.25%.

干预措施: Supra-iliac anterior quadratus lumborum block (Other)

Group PENG

Experimental

Patients will receive an ultrasound-guided pericapsular nerve group (PENG) block using 20mL of bupivacaine 0.25%.

干预措施: Pericapsular nerve group block (Other)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

研究点 (1)

Loading locations...

相似试验